retatrutide stomach pain Significantly Reduces Visceral Fat in Clinical Trials Retatrutide Side Effects: What to
Description
Mathur et al., Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents, Molecules, vol
The standard starting dose is 0.25 mg weekly
Gastrointestinal side effects Nausea, vomiting, and diarrhea may contribute to dehydration and electrolyte imbalances
This shift introduces a new challenge for R&D teams: sterilization as a constraint that can influence what types of therapies are feasible to develop and deliver
doi: 10.1016/j.eprac.2023.02.001
